United States v. Young

CourtCourt of Appeals for the Tenth Circuit
DecidedSeptember 20, 2024
Docket23-6094
StatusUnpublished

This text of United States v. Young (United States v. Young) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Young, (10th Cir. 2024).

Opinion

Appellate Case: 23-6094 Document: 61-1 Date Filed: 09/20/2024 Page: 1 FILED United States Court of Appeals UNITED STATES COURT OF APPEALS Tenth Circuit

September 20, 2024 FOR THE TENTH CIRCUIT ________________________________________ Christopher M. Wolpert Clerk of Court UNITED STATES OF AMERICA,

Plaintiff - Appellee, No. 23-6094 v. (D.C. No. 5:22-CR-00492-F-1) (W.D. Okla.) JEMERIO JACOBY YOUNG,

Defendant - Appellant. ___________________________________________

ORDER AND JUDGMENT * ____________________________________

Before BACHARACH, MORITZ , and FEDERICO, Circuit Judges. ____________________________________

Mr. Jemerio Young was convicted of possessing fentanyl with the

intent to distribute. 21 U.S.C. § 841(a)(1). For this conviction, the district

court imposed a sentence of 140 months.

Mr. Young appeals the sentence, challenging the district court’s

calculation of the guideline range. That calculation depended in part on the

quantity and type of drugs attributable to him. U.S.S.G. § 1B1.3(a).

* This order and judgment does not constitute binding precedent except under the doctrines of law of the case, res judicata, and collateral estoppel. But the order and judgment may be cited for its persuasive value if otherwise appropriate. Fed. R. App. P. 32.1(a); 10th Cir. R. 32.1(A). Appellate Case: 23-6094 Document: 61-1 Date Filed: 09/20/2024 Page: 2

In the presentence report, the probation officer addressed drugs

found in Mr. Young’s house. The district court attributed these drugs to

Mr. Young and said that they had contained fentanyl. Challenging this

statement, Mr. Young argues that the evidence didn’t show the presence of

fentanyl.

Preservation

In district court, Mr. Young denied possession of the drugs but not

the presence of fentanyl. In fact, Mr. Young appeared to acknowledge that

the drugs had contained fentanyl:

Mr. Young disputes possessing the fentanyl pills described in these paragraphs. He did not commit this act of possession, nor was the possession by other parties done in a jointly undertaken criminal activity.

R. vol. 2, at 29. The district court ultimately rejected Mr. Young’s

argument that he hadn’t possessed the drugs. But the court had no reason to

decide whether the drugs contained fentanyl.

Mr. Young argues that the district court nonetheless characterized the

drugs as fentanyl. Based on this purported characterization, Mr. Young

insists that he can challenge the court’s statement that the drugs contained

We disagree. An argument is preserved when a district court

“‘explicitly’ address[es] the merits of an issue.” See United States v.

Guinn, 89 F.4th 838, 847 (10th Cir. 2023) (quoting United States v.

2 Appellate Case: 23-6094 Document: 61-1 Date Filed: 09/20/2024 Page: 3

Johnson, 43 F.4th 1100, 1115 (10th Cir. 2022)). But the district court

didn’t explicitly address whether the evidence would permit

characterization of the drugs as fentanyl.

Granted, the court did refer to the drugs as fentanyl. But this

reference appeared only to acknowledge the parties’ mutual assumption

about the presence of fentanyl, and there’s nothing to suggest that the

district court was intending to make a separate finding of drug type based

on the evidence. See United States v. Gunn, 89 F.4th 838, 847 (10th Cir.

2023) (concluding that the district court hadn’t “explicitly addressed” the

appellate issue by referring to the merits without mention of the specifics

of the contention later raised in the appeal). We thus conclude that Mr.

Young failed to preserve his appellate argument involving the presence of

fentanyl in the drugs. See United States v. Deninno, 29 F.3d 572, 579–80

(10th Cir. 1994) (finding a forfeiture when the defendant objected to the

quantity of the drug but not its type).

The government characterizes that lapse as a waiver; Mr. Young

characterizes the lapse as a forfeiture. If Mr. Young is right, he could seek

reversal under the plain-error standard; if the government is right,

Mr. Young would have given up his right to seek reversal under any

standard. See United States v. Leffler, 942 F.3d 1192, 1196 (10th Cir.

1919) (forfeiture); United States v. Egli, 13 F.4th 1139, 1144 (10th Cir.

2021) (waiver).

3 Appellate Case: 23-6094 Document: 61-1 Date Filed: 09/20/2024 Page: 4

For the sake of argument, we can assume that Mr. Young is right in

characterizing the lapse as a forfeiture. Based on that assumption, we apply

the plain-error standard. See Davis v. United States, 589 U.S. 345, 140

S. Ct. 1060–62 (2020) (per curiam). Under that standard, Mr. Young must

show that the district court committed an error that was obvious. United

States v. Wells, 38 F.4th 1246, 1256 (10th Cir. 2022). An error would have

been obvious only if the district court’s findings had been

 “internally contradictory,”

 “wildly implausible,” or

 “in direct conflict with the evidence” presented to the sentencing court.

United States v. Cristerna-Gonzalez, 962 F.3d 1253, 1262–63 (10th Cir.

2020) (quoting United States v. Saro, 24 F.3d 283, 291 (D.C. Cir. 1994)).

In our view, Mr. Young hasn’t made that showing.

Absence of an Obvious Error

Mr. Young acknowledges that his attorney and the prosecutor

assumed that the drugs had contained fentanyl. See Appellant’s Opening

Br. at 28 (“[E]veryone present at sentencing appears to have taken for

granted that the pills were fentanyl (except perhaps Mr. Young who denied

knowledge of the pills and therefore could not state whether the pills were

fentanyl or not).”). The probation officer apparently shared that

assumption, referring in the presentence report to Mr. Young’s

4 Appellate Case: 23-6094 Document: 61-1 Date Filed: 09/20/2024 Page: 5

“‘[p]ossession of [f]entanyl.” R. vol. 2, at 7. Mr. Young objected, but not

because he questioned the presence of fentanyl. To the contrary, Mr.

Young denied possessing “the fentanyl as described in” the presentence

report. R. vol. 2, at 29; see p. 2, above.

On appeal, Mr. Young insists that by denying possession of the

drugs, he couldn’t have known what the drugs were. But Mr. Young never

denied knowledge of the drugs. 1

Granted, Mr. Young denied possessing those drugs. Possession

required not only knowledge, but also an intent to exercise control over the

drugs. United States v. Little, 829 F.3d 1177, 1182–83 (10th Cir. 2016). So

when Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Bonard Ray Deninno
29 F.3d 572 (Tenth Circuit, 1994)
United States v. Quinton Neal Fennell
65 F.3d 812 (Tenth Circuit, 1995)
United States v. Charles Verdel Farnsworth
92 F.3d 1001 (Tenth Circuit, 1996)
United States v. Martinez
824 F.3d 1256 (Tenth Circuit, 2016)
United States v. Little
829 F.3d 1177 (Tenth Circuit, 2016)
United States v. Alejandro Garcia-Lagunas
835 F.3d 479 (Fourth Circuit, 2016)
United States v. Dickerson
678 F. App'x 706 (Tenth Circuit, 2017)
United States v. Leffler
942 F.3d 1192 (Tenth Circuit, 2019)
Davis v. United States
589 U.S. 345 (Supreme Court, 2020)
United States v. Cristerna-Gonzalez
962 F.3d 1253 (Tenth Circuit, 2020)
United States v. Wells
38 F.4th 1246 (Tenth Circuit, 2022)
United States v. Buendia
73 F.4th 336 (Fifth Circuit, 2023)
United States v. Guinn
89 F.4th 838 (Tenth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Young, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-young-ca10-2024.